HELP:NASDAQ, Cybin Inc.

Why HELP stock fell on November 16

Cybin Inc. fell 13.5% on Monday, November 16, 2026, on 12,762,451 shares, 7.0 times its average daily volume. Headlines around the move:

HELP stock overview

Cybin Inc. (HELP:NASDAQ) closed at $6.78 on November 19, 2026, down 1.60% on the day. The stock trades 55.2% below its 52-week high of $15.15 and 80.3% above its 52-week low of $3.76. Over the past year, it gained 21.3%. Cybin Inc. is part of the Health Care sector.

Key figures

Price
$6.78
Day change
-1.60%
Volume
1,999,659
Average volume
1,821,568
Market cap
541M+
52-week range
$3.76 – $15.15
50-day average
$10.91
200-day average
$7.80

Price action over the past year

In 252 trading sessions since November 19, 2025, HELP closed higher on 120 days (48%). Its best day was June 25, 2026 (+18.27%) and its worst was March 5, 2026 (-33.88%). The stock moved 10% or more in a single session 17 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

HELP news

About Cybin Inc.

Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions. With promising class leading data, Cybin is working to change the mental health treatment landscape through the introduction of novel drugs that provide effective and durable results for patients. The Company is currently developing CYB003, a proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and CYB004, a proprietary deuterated N, N-dimethyltryptamine molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds.

Similar stocks

Find more stocks like HELP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.